IMPACT OF COVID-19 ON TUBERCULOSIS CASE DETECTION IN VIET NAM: A MODELLING ANALYSIS

IMPACT OF COVID-19 ON TUBERCULOSIS CASE DETECTION IN VIET NAM: A MODELLING ANALYSIS

Publication date: Mar 02, 2025

Background Viet Nam, a high-burden tuberculosis (TB) country, observed marked declines in TB notifications during the COVID-19 pandemic. We sought to determine whether and how COVID-19-related factors have influenced TB transmission and control, as well as their long-term effects, aiming to inform and enhance TB control strategies. Methods We developed a compartmental TB transmission model to estimate COVID-19’s impact on TB detection and transmission in Vietnam. We simulated future scenarios to evaluate the potential benefits of enhanced TB case detection. Results The COVID-19 pandemic significantly impacted TB control in Viet Nam, leading to a sharp decline in case detection in 2021. This resulted in approximately 1,900 new TB episodes (95% credible interval [CrI]: 200 – 5,100) and 1,100 TB-related deaths (95% CrI: 100 – 2,700) in that year. Projections suggest that by 2035, these disruptions could contribute to 22,000 additional TB episodes (95% CrI: 1,900 – 63,000) and 5,900 more deaths (95% CrI: 600 – 16,600). We predicted two hypothetical scenarios of enhancing TB case detection. Under the ambitious scenario, enhancing TB case detection could mitigate these potential impacts by preventing 17.8% of new TB episodes (95%CrI: 13.1% – 21.9%) and 34.2% (95%CrI: 31.5% – 37.0%) of TB-related deaths by 2035, compared to no enhancement. Conclusions COVID-19 disruptions have created a backlog of undiagnosed TB cases, increasing transmission and mortality. Sustained investment in diagnostics, healthcare resilience, and proactive policies is essential to mitigate long-term consequences.

PDF

Concepts Keywords
Fox Calibration
Healthcare Certified
Pandemic Covid
Cri
Detection
Https
Medrxiv
Nam
Pandemic
Preprint
Prevalence
Related
Transmission
Tuberculosis
Viet

Semantics

Type Source Name
disease MESH COVID-19
disease MESH TUBERCULOSIS
pathway KEGG Tuberculosis
disease IDO country
disease MESH infection
disease MESH latent infection
disease MESH death
disease IDO algorithm
disease IDO history
disease IDO process
disease MESH uncertainty
drug DRUGBANK Coenzyme M
disease IDO symptom
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH Infectious Diseases
drug DRUGBANK Guanosine
disease MESH latent tuberculosis infection
disease MESH hepatitis
disease MESH AIDS
disease MESH pulmonary tuberculosis

Download Document

Leave a Comment

Your email address will not be published. Required fields are marked *